Cancer – The Pipettepen

Blog / The Role of AI in Cancer Diagnosis and Disease Progression

September 9, 2026 / WinSPIRE: Science in the News /

When 69-year-old Dianne Covey went to the doctor with a persistent cough, a standard chest X-ray was taken. To the human eye, early-stage lung abnormalities can be incredibly difficult to diagnose. However, her scan was analyzed by an Artificial Intelligence (AI) tool called Annalise.ai, which flagged a microscopic area of concern. The tool caught her lung cancer at Stage 1.

This article is part of our WinSPIRE Science in the News series. Authors: Karla Caracheo Gonzalez and Mia McGonnel Jasionowski

Blog / How Gene Editing Could Beat Cancer

October 3, 2025October 3, 2025 / WinSPIRE: Science in the News /

In 2013, scientists showed that CRISPR was able to change the DNA of human cells. This technology has opened doors for finding new treatments for cancer.

This article is part of our WinSPIRE Science in the News series. Authors: Helen Diego Jimenez and Dulce Aguilar Cruz

Blog / The Use of Artificial Intelligence in Cancer Detection and Prediction

July 17, 2024August 19, 2024 / Hope Kellner /

Artificial intelligence (AI) is a popular and evolving technology that is often defined as computer programs or algorithms trained to “think like” or replicate human intelligence. The applications of AI…

Blog / The tumor microenvironment is a major challenge for CAR-T cancer immunotherapy

March 5, 2024 / Hope Kellner / 1

CAR-T immunotherapy is an up-and-coming cancer treatment; however, the tumor microenvironment in solid cancers poses a challenge. The tumor microenvironment suppresses the immune system from doing its job properly and instead, uses it to grow and thrive.

Blog / Radioactive Atoms: Superhero Origin Story or New and Effective Cancer Treatment?

August 8, 2023August 30, 2023 / Tiffany Peters /

Many people are under the impression that radioactivity causes cancer. Can we use radioactivity to cure it?

Blog / New peptide lures disease-causing proteins to their degrading demise

March 9, 2023 / Bree Iskandar /

Scientists recently discovered a new peptide that inhibits a disease-protein by recruiting it to an intracellular protein shredder. This peptide shows proof of concept for a potential class of drugs that act by degrading misbehaving proteins in the body.

#Cancer

Blog / The Role of AI in Cancer Diagnosis and Disease Progression

Blog / How Gene Editing Could Beat Cancer

Blog / The Use of Artificial Intelligence in Cancer Detection and Prediction

Blog / The tumor microenvironment is a major challenge for CAR-T cancer immunotherapy

Blog / Radioactive Atoms: Superhero Origin Story or New and Effective Cancer Treatment?

Blog / New peptide lures disease-causing proteins to their degrading demise

Blog / To fast or to feast: Cutting calories to curb cancer

Blog / Hope for difficult-to-treat cancers

Blog / Yeast in science: from glass to flask

Blog / Golden Medicine: Use of Plasmons for Cancer Therapy

Blog / The Science of Survivorship

Blog / One Cancer Drug to Rule Them All?

Blog / Cell-based Therapies at UNC using Good Manufacturing Practices, with Dr. Paul Eldridge

Blog / One in a Million: The Importance of Cellular Heterogeneity and the Power of Single Cell Sequencing

Blog / Sunscreen: Not Just for Carolina Blue Days!

Blog / Don’t Fear Nutella Just Yet!

Blog / Cells and Samples Have Race Too!

Blog / UNCseq: The Journey from Cancer Biopsy to Cable TV